201 related articles for article (PubMed ID: 25008344)
1. Identification of diet-derived constituents as potent inhibitors of intestinal glucuronidation.
Gufford BT; Chen G; Lazarus P; Graf TN; Oberlies NH; Paine MF
Drug Metab Dispos; 2014 Oct; 42(10):1675-83. PubMed ID: 25008344
[TBL] [Abstract][Full Text] [Related]
2. Identification of Intestinal UDP-Glucuronosyltransferase Inhibitors in Green Tea (
Tian DD; Kellogg JJ; Okut N; Oberlies NH; Cech NB; Shen DD; McCune JS; Paine MF
Drug Metab Dispos; 2018 May; 46(5):552-560. PubMed ID: 29467215
[TBL] [Abstract][Full Text] [Related]
3. A systematic approach to evaluate herb-drug interaction mechanisms: investigation of milk thistle extracts and eight isolated constituents as CYP3A inhibitors.
Brantley SJ; Graf TN; Oberlies NH; Paine MF
Drug Metab Dispos; 2013 Sep; 41(9):1662-70. PubMed ID: 23801821
[TBL] [Abstract][Full Text] [Related]
4. Milk Thistle Constituents Inhibit Raloxifene Intestinal Glucuronidation: A Potential Clinically Relevant Natural Product-Drug Interaction.
Gufford BT; Chen G; Vergara AG; Lazarus P; Oberlies NH; Paine MF
Drug Metab Dispos; 2015 Sep; 43(9):1353-9. PubMed ID: 26070840
[TBL] [Abstract][Full Text] [Related]
5. Targeted screen for human UDP-glucuronosyltransferases inhibitors and the evaluation of potential drug-drug interactions with zafirlukast.
Oda S; Fujiwara R; Kutsuno Y; Fukami T; Itoh T; Yokoi T; Nakajima M
Drug Metab Dispos; 2015 Jun; 43(6):812-8. PubMed ID: 25834030
[TBL] [Abstract][Full Text] [Related]
6. The effect of milk thistle (Silybum marianum) and its main flavonolignans on CYP2C8 enzyme activity in human liver microsomes.
Albassam AA; Frye RF; Markowitz JS
Chem Biol Interact; 2017 Jun; 271():24-29. PubMed ID: 28457856
[TBL] [Abstract][Full Text] [Related]
7. Two flavonolignans from milk thistle (Silybum marianum) inhibit CYP2C9-mediated warfarin metabolism at clinically achievable concentrations.
Brantley SJ; Oberlies NH; Kroll DJ; Paine MF
J Pharmacol Exp Ther; 2010 Mar; 332(3):1081-7. PubMed ID: 19934397
[TBL] [Abstract][Full Text] [Related]
8. Identification and characterization of in vitro inhibitors against UDP-glucuronosyltransferase 1A1 in uva-ursi extracts and evaluation of in vivo uva-ursi-drug interactions.
Park JB; Kim D; Min JS; Jeong S; Cho DY; Zheng YF; Yoon KD; Bae SK
Food Chem Toxicol; 2018 Oct; 120():651-661. PubMed ID: 30075316
[TBL] [Abstract][Full Text] [Related]
9. Semisynthesis, cytotoxicity, antiviral activity, and drug interaction liability of 7-O-methylated analogues of flavonolignans from milk thistle.
Althagafy HS; Graf TN; Sy-Cordero AA; Gufford BT; Paine MF; Wagoner J; Polyak SJ; Croatt MP; Oberlies NH
Bioorg Med Chem; 2013 Jul; 21(13):3919-26. PubMed ID: 23673225
[TBL] [Abstract][Full Text] [Related]
10. Evidence that unsaturated fatty acids are potent inhibitors of renal UDP-glucuronosyltransferases (UGT): kinetic studies using human kidney cortical microsomes and recombinant UGT1A9 and UGT2B7.
Tsoutsikos P; Miners JO; Stapleton A; Thomas A; Sallustio BC; Knights KM
Biochem Pharmacol; 2004 Jan; 67(1):191-9. PubMed ID: 14667942
[TBL] [Abstract][Full Text] [Related]
11. The effects of milk thistle (Silybum marianum) on human cytochrome P450 activity.
Kawaguchi-Suzuki M; Frye RF; Zhu HJ; Brinda BJ; Chavin KD; Bernstein HJ; Markowitz JS
Drug Metab Dispos; 2014 Oct; 42(10):1611-6. PubMed ID: 25028567
[TBL] [Abstract][Full Text] [Related]
12. Probe substrate and enzyme source-dependent inhibition of UDP-glucuronosyltransferase (UGT) 1A9 by wogonin.
Chengcheng G; Rui X; Tianheng M; Wei Y; Liqun P
Afr Health Sci; 2013 Sep; 13(3):551-5. PubMed ID: 24250287
[TBL] [Abstract][Full Text] [Related]
13. Structure-inhibition relationship of podophyllotoxin (PT) analogues towards UDP-glucuronosyltransferase (UGT) isoforms.
Qi JQ; Cao YF; Sun XY; Hong M; Fang ZZ; Meng DL; Sun DX
Pharmazie; 2015 Apr; 70(4):239-43. PubMed ID: 26012253
[TBL] [Abstract][Full Text] [Related]
14. Human UDP-Glucuronosyltransferase (UGT) 2B10: Validation of Cotinine as a Selective Probe Substrate, Inhibition by UGT Enzyme-Selective Inhibitors and Antidepressant and Antipsychotic Drugs, and Structural Determinants of Enzyme Inhibition.
Pattanawongsa A; Nair PC; Rowland A; Miners JO
Drug Metab Dispos; 2016 Mar; 44(3):378-88. PubMed ID: 26669329
[TBL] [Abstract][Full Text] [Related]
15. Characterization of in vitro glucuronidation clearance of a range of drugs in human kidney microsomes: comparison with liver and intestinal glucuronidation and impact of albumin.
Gill KL; Houston JB; Galetin A
Drug Metab Dispos; 2012 Apr; 40(4):825-35. PubMed ID: 22275465
[TBL] [Abstract][Full Text] [Related]
16. Assessment of a candidate marker constituent predictive of a dietary substance-drug interaction: case study with grapefruit juice and CYP3A4 drug substrates.
Ainslie GR; Wolf KK; Li Y; Connolly EA; Scarlett YV; Hull JH; Paine MF
J Pharmacol Exp Ther; 2014 Dec; 351(3):576-84. PubMed ID: 25253884
[TBL] [Abstract][Full Text] [Related]
17. Polymorphic gene regulation and interindividual variation of UDP-glucuronosyltransferase activity in human small intestine.
Strassburg CP; Kneip S; Topp J; Obermayer-Straub P; Barut A; Tukey RH; Manns MP
J Biol Chem; 2000 Nov; 275(46):36164-71. PubMed ID: 10748067
[TBL] [Abstract][Full Text] [Related]
18. The inhibition of UDP-glucuronosyltransferases (UGTs) by tetraiodothyronine (T4) and triiodothyronine (T3).
Chen DW; Du Z; Zhang CZ; Zhang WH; Cao YF; Sun HZ; Zhu ZT; Yang K; Liu YZ; Zhao ZW; Fu ZW; Gu WQ; Yu Y; Fang ZZ
Xenobiotica; 2018 Mar; 48(3):250-257. PubMed ID: 28285550
[TBL] [Abstract][Full Text] [Related]
19. Product inhibition of UDP-glucuronosyltransferase (UGT) enzymes by UDP obfuscates the inhibitory effects of UGT substrates.
Fujiwara R; Nakajima M; Yamanaka H; Katoh M; Yokoi T
Drug Metab Dispos; 2008 Feb; 36(2):361-7. PubMed ID: 17998297
[TBL] [Abstract][Full Text] [Related]
20. Evidence for differences in regioselective and stereoselective glucuronidation of silybin diastereomers from milk thistle (Silybum marianum) by human UDP-glucuronosyltransferases.
Jančová P; Siller M; Anzenbacherová E; Křen V; Anzenbacher P; Simánek V
Xenobiotica; 2011 Sep; 41(9):743-51. PubMed ID: 21524189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
